Grant: Engage Grants Program
University of Guelph
$25,000.00
Aptasensor Construction for Detection of Biological Contaminants**
FY 2018-19
Summary
Vital Biosciences (formerly Elucid Labs) is a Canadian biotechnology company located in Waterloo, Ontario, that develops point-of-care biosensor platforms for detection of biomarkers in biological fluids to overcome limitations in ubiquitously employed analytical methods and improve medical data acquisition, transmission time, as well as the overall patient experience. In this NSERC Engage application, Vital, with the cooperation of Dr. Manderville's laboratory at the University of Guelph (UOG), will endeavor to incorporate DNA aptamers into an existing antibody-based assay design by using immobilization strategies and advanced nanoscience to construct a general aptasensor platform. This project will focus on aptamer immobilization onto nanoparticles to enable in situ filtration and concentration of target molecules, plasmonic signal enhancement strategies, label free target acquisition and assay miniaturization. The binding of target molecules must be accompanied by a detectable signal change on a benchtop device at relevant concentrations, and must work with a very small (uL) amount of sample to demonstrate project success. This ENGAGE project has two major research objectives: (1) establish if aptamers can be incorporated in Vital's currently developed technology, and (2) employ assay components and functionalization techniques on aptasensors to expand their utility into complex matrices and potentially develop novel assay systems. To accomplish these goals, aptamers already established for thrombin (model protein target) and ochratoxin A (OTA, model small molecule target) will be modified with linking components for nanomaterial attachment and fluorescent dyes as the optical readout for target binding. Successful development of this system will cause continual diversification of the Vital commercial portfolio which, in turn, will lead to new revenue streams and company growth within South Western Ontario.
Program
Engage Grants Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
537058-2018
Name nom
Manderville, Richard
Department département
Chemistry
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
1
Nb partie
1
Application title
Aptasensor Construction for Detection of Biological Contaminants**
Keyword
NSERC
Application summary
Vital Biosciences (formerly Elucid Labs) is a Canadian biotechnology company located in Waterloo, Ontario, that develops point-of-care biosensor platforms for detection of biomarkers in biological fluids to overcome limitations in ubiquitously employed analytical methods and improve medical data acquisition, transmission time, as well as the overall patient experience. In this NSERC Engage application, Vital, with the cooperation of Dr. Manderville's laboratory at the University of Guelph (UOG), will endeavor to incorporate DNA aptamers into an existing antibody-based assay design by using immobilization strategies and advanced nanoscience to construct a general aptasensor platform. This project will focus on aptamer immobilization onto nanoparticles to enable in situ filtration and concentration of target molecules, plasmonic signal enhancement strategies, label free target acquisition and assay miniaturization. The binding of target molecules must be accompanied by a detectable signal change on a benchtop device at relevant concentrations, and must work with a very small (uL) amount of sample to demonstrate project success. This ENGAGE project has two major research objectives: (1) establish if aptamers can be incorporated in Vital's currently developed technology, and (2) employ assay components and functionalization techniques on aptasensors to expand their utility into complex matrices and potentially develop novel assay systems. To accomplish these goals, aptamers already established for thrombin (model protein target) and ochratoxin A (OTA, model small molecule target) will be modified with linking components for nanomaterial attachment and fluorescent dyes as the optical readout for target binding. Successful development of this system will cause continual diversification of the Vital commercial portfolio which, in turn, will lead to new revenue streams and company growth within South Western Ontario.